20 julio 2015
Results from a clinical trial investigating a new T cell receptor therapy that uses a person’s own immune system to recognize and destroy cancer cells demonstrated a clinical response in 80 percent of multiple myeloma patients with advanced disease after undergoing autologous stem cell transplants.img src=»http://feeds.feedburner.com/~r/sciencedaily/~4/pDLfJooDchE» height=»1″ width=»1″ alt=»»/
http://feeds.sciencedaily.com/~r/sciencedaily/~3/pDLfJooDchE/150720114749.htm
